Found: 118
Select item for more details and to access through your institution.
Impact of Bevacizumab Being Skipped due to Adverse Events of Special Interest for Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab: An Exploratory Analysis of the Phase III IMbrave150 Study.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 4, p. 401, doi. 10.1159/000535501
- By:
- Publication type:
- Article
Post-allogeneic Hematopoietic Stem Cell Transplantation Portal Hypertension Not Associated with Liver Cirrhosis, Veno-occlusive Disease, or Graft-versus-host Disease.
- Published in:
- Internal Medicine, 2024, v. 63, n. 11, p. 1563, doi. 10.2169/internalmedicine.2489-23
- By:
- Publication type:
- Article
Programmed cell death-1 is involved with peripheral blood immune cell profiles in patients with hepatitis C virus antiviral therapy.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0299424
- By:
- Publication type:
- Article
Characteristics of patients with longer treatment period of lenvatinib for unresectable hepatocellular carcinoma: A post-hoc analysis of post-marketing surveillance study in Japan.
- Published in:
- PLoS ONE, 2024, v. 19, n. 3, p. 1, doi. 10.1371/journal.pone.0298420
- By:
- Publication type:
- Article
Successful second‐line treatment with cabozantinib for hepatocellular carcinoma harboring cytoplasmic mesenchymal–epithelial transition factor amplification.
- Published in:
- Hepatology Research, 2024, v. 54, n. 3, p. 315, doi. 10.1111/hepr.13975
- By:
- Publication type:
- Article
Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 2, p. 193, doi. 10.1159/000531820
- By:
- Publication type:
- Article
Trajectories of Liver Fibrosis and Gene Expression Profiles in Nonalcoholic Fatty Liver Disease Associated With Diabetes.
- Published in:
- Diabetes, 2023, v. 72, n. 9, p. 1297, doi. 10.2337/db22-0933
- By:
- Publication type:
- Article
The developmental and structural uniqueness of the embryo of the extremophile viviparous nematode, Tokorhabditis tufae.
- Published in:
- Frontiers in Physiology, 2023, p. 1, doi. 10.3389/fphys.2023.1197477
- By:
- Publication type:
- Article
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines).
- Published in:
- Hepatology Research, 2023, v. 53, n. 5, p. 383, doi. 10.1111/hepr.13892
- By:
- Publication type:
- Article
Plasma Antithrombin III Levels Can Be a Prognostic Factor in Liver Cirrhosis Patients with Portal Vein Thrombosis.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 9, p. 7732, doi. 10.3390/ijms24097732
- By:
- Publication type:
- Article
Vegetable Oil-Peroxidation Product 'Hydroxynonenal' Causes Hepatocyte Injury and Steatosis via Hsp70.1 and BHMT Disorders in the Monkey Liver.
- Published in:
- Nutrients, 2023, v. 15, n. 8, p. 1904, doi. 10.3390/nu15081904
- By:
- Publication type:
- Article
Efficacy of a novel self-expandable metal stent with dumbbell-shaped flare ends for distal biliary obstruction due to unresectable pancreatic cancer.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-25186-2
- By:
- Publication type:
- Article
Alterations in Hepatocellular Carcinoma-Specific Immune Responses Following Hepatitis C Virus Elimination by Direct-Acting Antivirals.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11623, doi. 10.3390/ijms231911623
- By:
- Publication type:
- Article
Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer.
- Published in:
- Oncologist, 2022, v. 27, n. 10, p. e774, doi. 10.1093/oncolo/oyac157
- By:
- Publication type:
- Article
Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer.
- Published in:
- Oncologist, 2022, v. 27, n. 9, p. e774, doi. 10.1093/oncolo/oyac157
- By:
- Publication type:
- Article
FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome Inhibition.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 15, p. 8305, doi. 10.3390/ijms23158305
- By:
- Publication type:
- Article
Upregulation of the Long Noncoding RNA HULC by Hepatitis C Virus and Its Regulation of Viral Replication.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Oral Corticosteroids Impair Mucin Production and Alter the Posttransplantation Microbiota in the Gut.
- Published in:
- Digestion, 2022, v. 103, n. 4, p. 269, doi. 10.1159/000522039
- By:
- Publication type:
- Article
Peptide vaccine-treated, long-term surviving cancer patients harbor self-renewing tumor-specific CD8<sup>+</sup> T cells.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30861-z
- By:
- Publication type:
- Article
Comparative analysis of medical costs after hepatectomy versus radiofrequency ablation in patients with hepatocellular carcinoma in real‐world clinical practice.
- Published in:
- Hepatology Research, 2022, v. 52, n. 5, p. 471, doi. 10.1111/hepr.13756
- By:
- Publication type:
- Article
Response Evaluation Criteria in Cancer of the liver version 6 (Response Evaluation Criteria in Cancer of the Liver 2021 revised version).
- Published in:
- Hepatology Research, 2022, v. 52, n. 4, p. 329, doi. 10.1111/hepr.13746
- By:
- Publication type:
- Article
Dickkopf-1 Promotes Angiogenesis and is a Biomarker for Hepatic Stem Cell-like Hepatocellular Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 5, p. 2801, doi. 10.3390/ijms23052801
- By:
- Publication type:
- Article
BMP9-ID1 Signaling Activates HIF-1α and VEGFA Expression to Promote Tumor Angiogenesis in Hepatocellular Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 3, p. 1475, doi. 10.3390/ijms23031475
- By:
- Publication type:
- Article
Treatment patterns and medical costs after hepatectomy in real‐world practice for patients with hepatocellular carcinoma in Japan.
- Published in:
- Hepatology Research, 2021, v. 51, n. 10, p. 1073, doi. 10.1111/hepr.13701
- By:
- Publication type:
- Article
Tokorhabditis n. gen. (Rhabditida, Rhabditidae), a comparative nematode model for extremophilic living.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-95863-1
- By:
- Publication type:
- Article
Impact of hepatitis C virus on survival in patients undergoing resection of intrahepatic cholangiocarcinoma: Report of a Japanese nationwide survey.
- Published in:
- Hepatology Research, 2021, v. 51, n. 8, p. 890, doi. 10.1111/hepr.13676
- By:
- Publication type:
- Article
BMP9‐ID1 signaling promotes EpCAM‐positive cancer stem cell properties in hepatocellular carcinoma.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 8, p. 2203, doi. 10.1002/1878-0261.12963
- By:
- Publication type:
- Article
The dorsal hippocampus is required for the formation of long‐term duration memories in rats.
- Published in:
- European Journal of Neuroscience, 2021, v. 54, n. 2, p. 4595, doi. 10.1111/ejn.15328
- By:
- Publication type:
- Article
CX3CL1-CX3CR1 Signaling Deficiency Exacerbates Obesity-induced Inflammation and Insulin Resistance in Male Mice.
- Published in:
- Endocrinology, 2021, v. 162, n. 6, p. 1, doi. 10.1210/endocr/bqab064
- By:
- Publication type:
- Article
Ramucirumab in patients with advanced hepatocellular carcinoma and elevated α‐fetoprotein: Outcomes by treatment‐emergent ascites.
- Published in:
- Hepatology Research, 2021, v. 51, n. 6, p. 715, doi. 10.1111/hepr.13638
- By:
- Publication type:
- Article
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 Trial.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 3, p. 275, doi. 10.1159/000515553
- By:
- Publication type:
- Article
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Safety and efficacy of sorafenib followed by regorafenib or lenvatinib in patients with hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2021, v. 51, n. 2, p. 190, doi. 10.1111/hepr.13588
- By:
- Publication type:
- Article
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 5, p. 583, doi. 10.1159/000508724
- By:
- Publication type:
- Article
IL‐28B variant as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 10, p. 1813, doi. 10.1111/jgh.15035
- By:
- Publication type:
- Article
Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis.
- Published in:
- Life (2075-1729), 2020, v. 10, n. 9, p. 177, doi. 10.3390/life10090177
- By:
- Publication type:
- Article
Effects of adaptive immune cell therapy on the immune cell profile in patients with advanced gastric cancer.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 14, p. 4907, doi. 10.1002/cam4.3152
- By:
- Publication type:
- Article
Treatment Selection for Early to Intermediate Hepatocellular Carcinoma.
- Published in:
- Applied Sciences (2076-3417), 2020, v. 10, n. 13, p. 4607, doi. 10.3390/app10134607
- By:
- Publication type:
- Article
Comparative analysis of liver functional reserve during lenvatinib and sorafenib for advanced hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2020, v. 50, n. 7, p. 871, doi. 10.1111/hepr.13505
- By:
- Publication type:
- Article
Fatty acid-driven modifications in T-cell profiles in non-alcoholic fatty liver disease patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Direct-Acting Antiviral Agents Reduce the Risk of Malignant Transformation of Hepatobiliary Phase-Hypointense Nodule without Arterial Phase Hyperenhancement to Hepatocellular Carcinoma on Gd-EOB-DPTAEnhanced Imaging in the Hepatitis C Virus-Infected Liver
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 3, p. 261, doi. 10.1159/000504889
- By:
- Publication type:
- Article
Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Management of biliary stricture in patients with IgG4-related sclerosing cholangitis.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0232089
- By:
- Publication type:
- Article
Study Protocol for Pleiotropic Effects and Safety of Sodium–Glucose Cotransporter 2 Inhibitor Versus Sulfonylurea in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 2, p. 549, doi. 10.1007/s13300-020-00762-9
- By:
- Publication type:
- Article
REFLECT-a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Gut-derived Enterococcus faecium from ulcerative colitis patients promotes colitis in a genetically susceptible mouse host.
- Published in:
- Genome Biology, 2019, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13059-019-1879-9
- By:
- Publication type:
- Article
Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinoma.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 10, p. 2701, doi. 10.1002/ijc.32339
- By:
- Publication type:
- Article
Serum C16:1n7/C16:0 ratio as a diagnostic marker for non‐alcoholic steatohepatitis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 10, p. 1829, doi. 10.1111/jgh.14654
- By:
- Publication type:
- Article